Combutol 400 Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Combutol 400 Tablet contains ethambutol, an antitubercular medicine. Its labelling describes it for the treatment of tuberculosis (TB), usually in combination with other antitubercular medicines. It is described as slowing the growth of the bacteria that cause TB. Symptoms may improve before the infection is fully cleared, and the full course must still be completed.

Active ingredient
Ethambutol hydrochloride
Strength
400 mg
Dosage form
Oral tablet
Therapeutic class
Antitubercular agent
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with ethambutol and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of tuberculosis, in combination with other antitubercular medicines
  • Described as slowing the growth of the bacteria that cause tuberculosis
  • Described as needing the full course to be completed even after symptoms improve
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Swallowed whole with water; tablets should not be broken, crushed, or chewed
  • Taken at about the same time each day, with or without food
  • A missed dose should be taken when remembered, unless the next dose is close — two doses should not be taken at once
  • The full course should be completed; stopping midway is described as risking serious health setbacks

Described Side Effects

Described side effects include:

  • Visual impairment (blurred vision or reduced sharpness)
  • Colour blindness (difficulty telling red from green)

Vision changes are described as needing prompt medical attention, as eyesight is monitored during treatment. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • The doctor should be told if the patient is diabetic or has any other current medical condition
  • Monitoring of liver function, vision, and thyroid function is described as carried out during treatment
  • Two doses should not be taken at once to make up for a missed dose
  • Any persistent or severe side effect should be reviewed by a clinician

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains ethambutol and is used with other antitubercular medicines to treat tuberculosis, described as slowing the growth of the bacteria that cause TB. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as swallowed whole with water at about the same time each day, with or without food, and not broken, crushed, or chewed. The full course should be completed even after symptoms improve.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services